Skip to content

Living well with dementia groups in primary care

A feasibility study to translate LIVing Well with DEMentia groups into a primary care context

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN05413972
Enrollment
16
Registered
2013-10-25
Start date
2013-09-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia (Alzheimer's disease, vascular dementia and Lewy-body disease) Nervous System Diseases Dementia in Alzheimer disease, vascular dementia, Lewy body(ies)(dementia)(disease)

Interventions

Participants will attend one of two Living Well with Dementia groups, with between 4 and 12 participants attending each group, each of which runs for 10 weeks. The Living Well with Dementia (LIVDEM) g

Sponsors

Avon and Wiltshire Mental Health Partnership NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The principal inclusion criteria are that participants: 1. Must have received a diagnosis of dementia within the previous 18 months. This diagnosis may be of 1.1. Probable Alzheimer?s disease according to the National Institute of Neurological and Communicative Disorders and Stroke - Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria (McKhann et al. 1984) 1.2. Probable vascular dementia according to the NINDS-AIREN criteria (Roman et al. 1993) 1.3. Dementia with Lewy bodies according to the ?consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)? (McKeith et al. 1996) 2. Participants should acknowledge, at least occasionally, that they have a memory problem 3. Be willing to attend a group program 4. Have adequate communication skills to enable group participation 5. Have a MMSE (Mini-Mental State Examination; Folstein, Folstein & McHugh, 1975) score of at least 18

Exclusion criteria

Exclusion criteria: Participants will be excluded from the study if: 1. They have a significant pre-morbid history of functional mental health problems (e.g., psychosis) 2. Received a diagnosis of frontotemporal dementia (Neary et al. 1988) 3. If participants have taken part in similar research or dementia group projects in the past

Design outcomes

Primary

MeasureTime frame
Quality of life is measured using the Quality of Life in Alzheimer?s disease scale (QoL-AD) during the first and the final sessions.

Secondary

MeasureTime frame
The LIFT psychology service, like all Improving Access to Psychological Therapies (IAPT) services, are required to administer the Minimum Data Set (MDS) for all therapy participants at the end of every session. This includes: 1. Demographic information (e.g., ethnicity, address, religion, economic status) 2. The Patient Health Questionnaire (PHQ-9) 3. Generalized Anxiety Disorder 7-item (GAD-7) scale 4. Work and Social Adjustment Scale (WSAS)

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026